1,3-dipropyl-8-cyclopentylxanthine has been researched along with adenosine amine congener in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; van Galen, PJ; Williams, M | 1 |
| Adén, U; Fredholm, BB; Hagberg, H; Leverin, AL | 1 |
1 review(s) available for 1,3-dipropyl-8-cyclopentylxanthine and adenosine amine congener
| Article | Year |
|---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
1 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and adenosine amine congener
| Article | Year |
|---|---|
Adenosine A(1) receptor agonism in the immature rat brain and heart.
Topics: Adenosine; Animals; Animals, Newborn; Binding, Competitive; Body Temperature; Brain; Brain Ischemia; Dose-Response Relationship, Drug; Female; Guanosine 5'-O-(3-Thiotriphosphate); Heart; Heart Rate; Hypoxia; Iodine Radioisotopes; Male; Myocardium; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Rectum; Sulfur Radioisotopes; Time Factors; Xanthines | 2001 |